Minerva Neurosciences (NERV) Tops Q2 EPS by 14c

Minerva Neurosciences (NASDAQ: NERV) reported Q2 EPS of ($0.27), $0.14 better than the analyst estimate of ($0.41).

For earnings history and earnings-related data on Minerva Neurosciences (NERV) click here.

You May Also Be Interested In

• MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
• UBS Reiterates Buy Rating on Option Care Health (OPCH) Following Check-in Call Ahead of Quiet Period
• AutoZone (AZO) Tops Q4 EPS by $1.76, Misses on Revenue